Sign in
Not yet taking people in United StatesNo phase

Umbilical cord tissue product for joint, tendon, ligament and spine conditions

Tests an umbilical allograft for pain and function in adults with musculoskeletal conditions.

Key facts

Who runs it
R3 Stem Cell
Where
Encino, United StatesSee the site
Trial code
Registry title
Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions
Status
Not yet recruiting
People taking part
200 people, planned
Started
1 Jan 2022
Expected to end
1 Jan 2030
Type of study
Interventional
Treatments tested
  • Umbilical Allograft
Record updated
17 September 2021

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a muscle, joint, tendon, ligament or other musculoskeletal condition. They get an umbilical cord tissue product to see if it eases pain and improves function.

Age
18 years and over.
Sex
All sexes can join.
Disease stage
Any type of musculoskeletal condition, such as osteoarthritis, tendinitis, sports injury, degenerative disc disease, ligament injury, neuropathy or pelvic pain.

Main reasons for not taking part

  • Active infection
  • Pregnancy
  • Breastfeeding
  • Clotting (blood clotting) disorder
  • Not able to attend follow-up visits or answer follow-up by phone or email

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age 18 and over
  • Ability to attend follow up visits or at least converse on phone or complete email follow up forms
  • Competent to understand the study protocol and provide voluntary informed consent

Who cannot take part

  • Active Infection
  • Clotting disorder
  • Pregnancy, Lactating

Where in United States

  • Advanced Stem Cell InstituteEncino, United StatesContact: David Greene, PhDNot yet recruiting

About the trial

What the trial wants to find out

The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.

The group in the trial

  • Umbilical AllograftTreatment being tested

    The study is nonrandomized with one arm. Depending on the body area being treated, the amount of the product utilized will be either 1.0cc's or 2cc's.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of Regenerative Medicine Outcomes With Umbilical Allograft for Musculoskeletal Conditions
Plain-language title
Umbilical cord tissue product for joint, tendon, ligament and spine conditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 September 2021